Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Thursday, July 10, 2025
Soleno’s $200 Million Public Offering
Renasant’s $55 Million Seed Round…More
Wednesday, July 9, 2025
Merck’s $10 Billion Acquisition of Verona
Actithera’s $76 Million Series A
Tuesday, July 8, 2025
Concentra $216 Million Acquisition with CARGO
Rallybio’s $25 Million Equity Investment
LakeShore’s $15 Million Private Placement
Lixte’s $2 Million Registered Direct OIffering
AB Science’s $2 Million Private Placement
Monday, July 7, 2025
EvlaBio’s $25 Million Seed Round
Synfini’s $9 Million Seed Round
Thursday, July 3, 2025
INOVIO’s $25 Million Public Offering
Wednesday, July 2, 2025
Curis’s $7 Million Registered Direct Offering
Tuesday, July 1, 2025
Apellis’s $300 Million Royalty Financing
BioMarin’s $270 Million Acquisition of Inozyme
Nektar’s $100 Million Public Offering
Concentra’s $82 Million Acquisition of IGM
Arrivent’s $75 Million Public Offering
atai’s $50 Million Private Placement
Oragenics’s $16 Million Public Offering
GeoVax’s $6 Million Public Offering
Cellectar’s $6 Million Public Offering
Lixte’s $5 Million Private Placement
Indaptus’s $3 Million Private Placement
Algernon’s $621 Thousand Private Placement
Monday, June 30, 2025
BridgeBio’s $300 Million Royalty Financing
Dyne’s $200 Million Public Offering & $275 Million Debt Financing
Gallant’s $18 Million Series B
Friday, June 27, 2025
CorMedix’s $85 Million Public Offering
Channel’s Merger with Pelthos and $50 Million Private Placement
Lyra’s $15 Million Registered Direct Offering
XOMA’s $8 Million Acquisition of Turnstone…More
Bone’s $5 Million Public Offering
InMed’s $5 Million Private Placement
Thursday, June 26, 2025
Kymera’s $250 Million Public Offering
Vor Bio’s $175 Million Private Placement…More
Achieve Life’s $45 Million Public Offering
Reviva’s $10 Million Public Offering
Artelo’s $1 Million Private Placement
Sponsors
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck